|

Mid-day market update: Stocks extend losses, Dow tumbles over 400 points

U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would recognize the independence of two Russian-led breakaway regions of Ukraine and ordered Russian troops to go into eastern Ukraine.

The Dow traded down 1.31% to 33,631.65 while the NASDAQ fell 1.42% to 13,356.05. The S&P also fell, dropping, 1.08% to 4,301.81.

Leading and Lagging Sectors

Utilities shares slipped by just 0.1% on Tuesday. Meanwhile, top gainers in the sector included Empresa Distribuidora y Comercializadora Norte Sociedad Anónima EDN +6.73% (Get Free Alerts for EDN), up 7% and Companhia de Saneamento Básico do Estado de São Paulo - SABESP SBS +6.35% up 7%.

In trading on Tuesday, consumer discretionary shares tumbled by 3.3%.

Top Headline

Home Depot Inc HD -9.55% reported better-than-expected earnings for its fourth quarter and raised its dividend.

Home Depot reported fourth-quarter FY21 sales growth of 10.7% year-on-year, to $35.72 billion, beating the analyst consensus of $34.87 billion. EPS of $3.21 beat the analyst consensus of $3.17.

Home Depot raised the quarterly dividend by 15% to $1.90 from $1.65 per share, payable on March 24, 2022, to shareholders of record on the close of business on March 10, 2022.

The company expects FY22 EPS growth to be in the low single digits. Home Depot sees FY22 sales and comparable sales growth to be slightly positive.

Equities Trading UP

Meritor, Inc. MTOR +44.95% shares shot up 45% to $35.81. Cummins Inc CMI -1.69% agreed to acquire electric powertrain solutions provider Meritor for about $3.7 billion, including assumed debt and net of acquired cash.

Shares of Indonesia Energy Corporation Limited INDO +64.37% got a boost, shooting 58% to $7.09.

Ocugen, Inc. OCGN +24.27% shares were also up, gaining 29% to $4.46 after the company announced the FDA lifted its clinical hold on the company's COVID-19 vaccine study in the US.

Equities Trading DOWN

Allarity Therapeutics, Inc. ALLR -31.03% shares tumbled 31% to $4.5750. The FDA provided Allarity Therapeutics with a Refusal to File (RTF) letter for a marketing application for dovitinib for the third-line treatment of metastatic renal cell carcinoma (mRCC).

Shares of Dogness (International) Corporation DOGZ -40.98% were down 40% to $2.55 after the company reported entry into agreement for registered direct offering of approximately $5.66 million of class A common shares.

Homology Medicines, Inc. FIXX -31.22% was down, falling 31% to $2.6601. The FDA placed a clinical hold on Homology Medicines’ pheNIX gene therapy trial of HMI-102 from the FDA. An official clinical hold letter is expected within 30 days.

Commodities

In commodity news, oil traded up 2.1% to $93.00, while gold traded up 0.3% to $1,905.10.

Silver traded up 1.2% Tuesday to $24.275 while copper fell 0.1% to $4.5085.

Euro zone

European shares were mixed today. The eurozone’s STOXX 600 gained 0.07%, London’s FTSE 100 rose 0.13%, while Spain’s IBEX 35 Index rose 0.05%. The German DAX fell 0.26%, French CAC 40 slipped 0.01% and Italy’s FTSE MIB Index fell 0.02%.

The UK government reported a £2.9 billion surplus in its public finances in January, versus a £2.5 billion deficit a year ago. The Ifo Business Climate indicator for Germany climbed to 98.9 in February from a revised level of 96 in January. The annual inflation rate in Italy increased to 4.8% in January from 3.9% in the earlier month.

Economics

The S&P CoreLogic Case-Shiller home price index surged 18.6% year-over-year in December.

The FHFA House Price Index rose 1.2% from a month ago in December.

The IHS Markit manufacturing PMI rose to 57.5 in February from 55.5 in the previous month, while services PMI climbed to 56.7 from 51.2.

The Conference Board’s consumer confidence index fell to 110.5 in February from previous reading of 111.1.

Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 3:30 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD edges above 1.1750 due to ECB-Fed policy divergence

EUR/USD has recovered its recent losses registered in the previous session, trading around 1.1760 during the Asian hours on Friday. Traders will likely observe Germany’s Manufacturing Purchasing Managers’ Index data later in the day.

GBP/USD gathers strength above 1.3450 on Fed rate cut bets, BoE's gradual policy path

The GBP/USD pair gathers strength to around 1.3480 during the early Asian session on Friday. Expectations of the US Federal Reserve rate cuts this year weigh on the US Dollar against the Pound Sterling. Philadelphia Fed President Anna Paulson is set to speak later on the weekend. 

Gold climbs to near $4,350 on Fed rate cut bets, geopolitical risks

Gold price rises to near $4,345 during the early Asian session on Friday. Gold finished 2025 with a significant rally, achieving an annual gain of around 65%, its biggest annual gain since 1979. The rally of the precious metal is bolstered by the prospect of further US interest rate cuts in 2026 and safe-haven flows.

Bitcoin, Ethereum and Ripple enter the New Year with breakout hopes

Bitcoin, Ethereum, and Ripple entered the new year trading at key technical levels on Friday, as traders seek fresh directional cues in January. With BTC locked in a tight range, ETH is approaching its 50-day Exponential Moving Average, while XRP is nearing resistance. A clear breakout across these top three cryptocurrencies could help define market momentum in the opening weeks of the year.

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Crypto market outlook for 2026

Year 2025 was volatile, as crypto often is.  Among positive catalysts were favourable regulatory changes in the U.S., rise of Digital Asset Treasuries (DAT), adoption of AI and tokenization of Real-World-Assets (RWA).